FDA Approves First CDx for Expanded EGFR TKI Therapies in NSCLC Patients
The group claim will also enable the test to be used as a CDx for any future approved EGFR TKI therapies targeting the same mutations.
Read More
Search Results for: lung cancer
FDA Approves New FoundationOne Liquid CDx Companion Diagnostic Indications for 3 Cancer Therapies
FDA approved FoundationOne Liquid CDx for three new companion diagnostic indications: Piqray in advanced or metastatic breast cancer; Rubraca in advanced ovarian cancer; and Alecensa in a certain type of metastatic non-small cell lung cancer.
Read More
FDA Approves FoundationOne CDx as Companion Diagnostic to Detect NTRK Fusions Across All Solid Tumors
The tissue-based comprehensive genomic profiling test is currently approved as a companion diagnostic for more than 20 targeted therapies.
Read More
InterVenn Biosciences IDs Potential Covid-19 Susceptibility Markers
The study demonstrates differential glycoproteomic profiles among covid-19-symptomatic and asymptomatic patients.
Read More
‘Coming into Their Own’: FDA Approval of Liquid Biopsy Tests Puts Early, Less Invasive Cancer Detection in Broader Reach
Simple blood tests to replace painful, invasive biopsies for cancer diagnosis will soon become more common after several recent FDA approvals, according to a report in USA Today.
Read More